Takeshi Tanaka

official title

Senior Assistant Professor

Research theme

Clinical Infectious Diseases, Infection Control, Antimicrobial Resistance, Antimicrobial stewardship (AMS), Vaccines

Faculties & Schools

Infection Control and Education Center

Qualifications

M.D., Ph.D

Research gate or Linked-in account links

https://www.researchgate.net/profile/Takeshi-Tanaka-8

www.linkedin.com/in/takeshi-tanaka-b612235

Affiliation(s)

The School of Tropical Medicine and Global Health (TMGH) Nagasaki University

Background

2002-2004: Residency training in internal medicine(Nagasaki University Hospital and Japanese Red Cross Nagasaki Genbaku Hospital)
2004-2006: Teaching hospitals in Nagasaki Prefecture.
2006-2011: Staff Physician, Department of Infectious Diseases, Nagasaki University Hospital
2011-2013: Affiliate Researcher (Henson Lab), National Jewish Health, Colorado, and Post-Doctoral Research Fellow (Vandivier Lab), Department of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Colorado, USA.
2013-2014: Staff Physician/Infectious Diseases Specialist(Consultant), Assistant Professor, Department of Infectious Diseases, Nagasaki University Hospital
2024-2018：Staff Physician/Infectious Diseases Specialist(Consultant), Senior Assistant Professor, Department of Infectious Diseases, Nagasaki University Hospital
2018- Present: Senior Assistant Professor, Infectious Diseases Physician (Consultant), Infection Control Doctor, Infection Control and Education Center, Nagasaki University HospitalSep 2022- Present: Affiliated faculty, The School of Tropical Medicine and Global Health (TMGH) Nagasaki UniversitySep 2022- Present: Affiliated faculty, The School of Tropical Medicine and Global Health (TMGH) Nagasaki University

Other

Dec 14-29, 2019: JICA The Japan Disaster Relief Team (JDR), “Infectious Diseases Response Team” for measle outbreak in Samoa, dispatched physician
2022: JICA project for Strengthening Countermeasures against Infectious Diseases in Mexico, as an infectious disease advisor visit.
2022-2024: International Course for Capacity Building in Genomic Surveillance of Infectious Diseases for Central America and the Caribbean countries (course in Gorgas Memorial Institute, Panama)
Dec,2024：Support for Infection Control in Shelters during the Noto Peninsula Earthquake (Dispatched as an active member of the Disaster Infection Control Team (DICT) of the Japanese Society for Infection Prevention and Control)

Teaching

Nagasaki University

・Lecture on Infectious Diseases (3rd grade, School of Dentistry/4th grade, School of Pharmacy)

・Lectures on Infectious Diseases (2nd grade medical students)

・TMGH: MTM / Diploma /TTM: PPE (personal protection equipment) infection control practical session

Other

・Member of Introduction and Training Team, member of Working Group for JICA, The Japan Disaster Relief Team (JDR), “Infectious Diseases Response Team”

Research

Managing Infections in Immunocompromised Patients (including vaccination strategy for transplant patients), HIV/AIDS epidemiology in Japan, Improving the Accuracy of LTBI(Latent Tubercurosis Infection) Diagnostic Methods, Regulation of vascular permeability (ARDS and septic shock)

The country/countries where you work currently

Japan, Indonesia, Panama, Mexico, Philippines

Five MOST IMPORTANT/INTERESTING recent publications

Tanaka T, Oshima K, Kawano K, Tashiro M, Kakiuchi S, Tanaka A, Fujita A, Ashizawa N, Tsukamoto M, Yasuoka A, Teruya K, Izumikawa K. Nationwide Longitudinal Annual Survey of HIV/AIDS Referral Hospitals in Japan From 1999 to 2021: Trend in Non-AIDS-defining Cancers Among Individuals Infected With HIV-1. J Acquir Immune Defic Syndr. 2024 May 1;96(1):1-10.
Yasuda I, Saludar NR, Sayo AR, Suzuki S, Yokoyama A, Ozeki Y, Kobayashi H, Nishiyama A, Matsumoto S, Cox SE, Tanaka T*, Yamashita Y*. Evaluation of cytokine profiles related to Mycobacterium tuberculosis latent antigens using a whole-blood assay in the Philippines. Front Immunol. 2024 Apr 10;15:1330796. * shared last authorship
Tanaka T, Kakiuchi S, Tashiro M, Fujita A, Ashizawa N, Eguchi S, Kenmochi T, Egawa H, Izumikawa K. Adherence to recommended vaccination policies for pre- and post-solid organ transplantation patients: A national questionnaire survey in Japan. Vaccine 2023. 41(52):7682-7688,2023.
Tanaka T, Tashiro M, Ota K, Fujita A, Sawai T, Kadota J, Fukuda Y, Sumiyoshi M, Ide S, Tachikawa N, Fujii H, Hibino M, Shiomi H, Izumida M, Matsui K, Yamauchi M, Takahashi K, Yamanashi H, Sugimoto T, Akabame S, Umeda M, Shimizu M, Hosogaya N, Kosai K, Takeda K, Iwanaga N, Ashizawa N, Hirayama T, Takazono T, Yamamoto K, Imamura Y, Miyazaki T, Kobayashi Y, Ariyoshi K, Mukae H, Yanagihara K, Kita K, Izumikawa K. Safety and efficacy of 5-aminolevulinic acid phosphate/iron in mild-to-moderate coronavirus disease 2019: A randomized exploratory phase II trial. Medicine (Baltimore). 2023 Aug 25;102(34):e34858.
Tanaka T, Mori M, Sekino M, Higashijima U, Takaki M, Yamashita Y, Kakiuchi S, Tashiro M, Morimoto K, Tasaki O, Izumikawa K. Impact of plasma 5-hydroxyindoleacetic acid, a serotonin metabolite, on clinical outcome in septic shock, and its effect on vascular permeability. Sci Rep. 11(1):14146, 2021.

Message

As an infectious disease specialist, I am involved in the management (treatment and prevention) of various infectious diseases, including HIV/AIDS, tuberculosis, vaccine management, drug resistance, Antimicrobial stewardship (AMS), nosocomial infection control, and zoonosis, which constitute significant challenges in low- and middle-income countries. Furthermore, given the management of infections and severe infections in severely immunocompromised patients, the control of increased vascular permeability, a crucial pathophysiological aspect of severe infections, is also a focus of research.

Faculty